Jacobs BC - Search Results

1

Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA; IGOS Consortium. Verboon C, et al. Among authors: jacobs bc. J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):113-121. doi: 10.1136/jnnp-2019-321496. Epub 2019 Oct 5. J Neurol Neurosurg Psychiatry. 2020. PMID: 31586949

2

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.

Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. Jacobs BC, et al. Brain. 2003 Oct;126(Pt 10):2220-34. doi: 10.1093/brain/awg235. Epub 2003 Jul 22. Brain. 2003. PMID: 12876146

3

The Guillain-Barré syndrome: a true case of molecular mimicry.

Ang CW, Jacobs BC, Laman JD. Ang CW, et al. Among authors: jacobs bc. Trends Immunol. 2004 Feb;25(2):61-6. doi: 10.1016/j.it.2003.12.004. Trends Immunol. 2004. PMID: 15102364 Review.

4

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: jacobs bc. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

5

Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.

van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH. van Sorge NM, et al. Among authors: jacobs bc. J Neuroimmunol. 2005 May;162(1-2):157-64. doi: 10.1016/j.jneuroim.2005.01.016. J Neuroimmunol. 2005. PMID: 15833371

6

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Kuijf ML, et al. Among authors: jacobs bc. J Neurol Sci. 2005 Dec 15;239(1):37-44. doi: 10.1016/j.jns.2005.07.009. Epub 2005 Sep 8. J Neurol Sci. 2005. PMID: 16154154

7

Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Godschalk PC, Gilbert M, Jacobs BC, Kramers T, Tio-Gillen AP, Ang CW, Van den Braak N, Li J, Verbrugh HA, Van Belkum A, Endtz HP. Godschalk PC, et al. Among authors: jacobs bc. Microbes Infect. 2006 Jan;8(1):248-53. doi: 10.1016/j.micinf.2005.06.022. Epub 2005 Sep 13. Microbes Infect. 2006. PMID: 16213180 Free article.

8

Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barré syndrome?

Kuijf ML, Ang CW, van Doorn PA, Niesters HG, Jacobs BC. Kuijf ML, et al. Among authors: jacobs bc. J Infect Dis. 2006 May 15;193(10):1471-2; author reply 1472-3. doi: 10.1086/503440. J Infect Dis. 2006. PMID: 16619197 No abstract available.

9

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: jacobs bc. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

10

Predicting the course of Guillain-Barré syndrome.

van Doorn PA, Jacobs BC. van Doorn PA, et al. Among authors: jacobs bc. Lancet Neurol. 2006 Dec;5(12):991-3. doi: 10.1016/S1474-4422(06)70606-8. Lancet Neurol. 2006. PMID: 17110272 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page